Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of C6 Ceramide NanoLiposome in Patients With Advanced Solid Tumors

NCT02834611 is registered in ClinicalTrials.gov with Keystone Nano, Inc as lead sponsor.

NCT NCT02834611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02834611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of C6 Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Lead sponsor
Keystone Nano, Inc
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2017
Completion date
November 1, 2023
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, carcinoma, solid tumors, tumor